全文获取类型
收费全文 | 6587篇 |
免费 | 465篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 170篇 |
妇产科学 | 125篇 |
基础医学 | 1014篇 |
口腔科学 | 154篇 |
临床医学 | 622篇 |
内科学 | 1698篇 |
皮肤病学 | 122篇 |
神经病学 | 761篇 |
特种医学 | 168篇 |
外科学 | 598篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 391篇 |
眼科学 | 67篇 |
药学 | 509篇 |
中国医学 | 13篇 |
肿瘤学 | 654篇 |
出版年
2024年 | 6篇 |
2023年 | 67篇 |
2022年 | 166篇 |
2021年 | 279篇 |
2020年 | 144篇 |
2019年 | 177篇 |
2018年 | 236篇 |
2017年 | 178篇 |
2016年 | 195篇 |
2015年 | 256篇 |
2014年 | 290篇 |
2013年 | 332篇 |
2012年 | 562篇 |
2011年 | 568篇 |
2010年 | 287篇 |
2009年 | 258篇 |
2008年 | 455篇 |
2007年 | 461篇 |
2006年 | 396篇 |
2005年 | 393篇 |
2004年 | 330篇 |
2003年 | 339篇 |
2002年 | 269篇 |
2001年 | 48篇 |
2000年 | 34篇 |
1999年 | 37篇 |
1998年 | 36篇 |
1997年 | 30篇 |
1996年 | 30篇 |
1995年 | 19篇 |
1994年 | 18篇 |
1993年 | 16篇 |
1992年 | 24篇 |
1991年 | 19篇 |
1990年 | 19篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1974年 | 7篇 |
1971年 | 5篇 |
1970年 | 5篇 |
1969年 | 4篇 |
排序方式: 共有7113条查询结果,搜索用时 15 毫秒
51.
Silvia Ferri Bernardo Stefanini Lorenzo Mulazzani Margherita Alvisi Francesco Tovoli Simona Leoni Luca Muratori Tommaso Lotti Alessandro Granito Luigi Bolondi Fabio Piscaglia 《Nutrients》2022,14(12)
The role of moderate alcohol consumption in the evolution of NAFLD is still debated. The aim of this study is to evaluate the impact of current and lifelong alcohol consumption in patients with NAFLD. From 2015 to 2020, we enrolled 276 consecutive patients fulfilling criteria of NAFLD (alcohol consumption up to 140 g/week for women and 210 g/week for men). According to their current alcohol intake per week, patients were divided in: abstainers, very low consumers (C1: <70 g/week) and moderate consumers (C2). We created a new tool, called LACU (Lifetime Alcohol Consuming Unit) to estimate the alcohol exposure across lifetime: 1 LACU was defined as 7 alcohol units per week for 1 drinking year. Patients were divided into lifelong abstainers and consumers and the latter furtherly divided into quartiles: Q1-Q4. Stratification according to alcohol intake, both current and cumulative as estimated by LACU, showed that very low consumers (C1 and Q1-Q3) displayed lower frequency of cirrhosis and hepatocellular carcinoma compared to abstainers and moderate consumers (C2 and Q4). We can speculate that up to one glass of wine daily in the context of a Mediterranean diet may be a long-term useful approach in selected NAFLD patients. 相似文献
52.
Rosanna Palmeri Francesco Corallo Lilla Bonanno Simona Curr Paola Merlino Giuseppe Di Lorenzo Placido Bramanti Silvia Marino Viviana Lo Buono 《Medicine》2022,101(26)
Apathy and impulsiveness are 2 common non-motor symptoms in Parkinson disease that could occur in different periods or simultaneously. Apathy and impulsiveness could be interpreted as opposite extremes of a spectrum of motivated behavior dependent on dopaminergic dysfunction, in which, impulsivity, is a result of a hyperdopaminergic state, whereas apathy is viewed as a hypodopaminergic. The study aimed to investigate the presence of impulsiveness and other neuropsychiatric symptoms in Parkinson disease patients with apathy symptoms.Eighty-one patients with Parkinson disease were enrolled in this retrospective study. All subjects were evaluated by the Italian version of the Dimensional Apathy Scale and the Barratt Impulsiveness Scale-version 11, to assess, respectively, apathy and impulsiveness; they were divided into 2 groups (apathy and no apathy). All patients were administered also with questionnaires assessing depressive and anxious symptoms.Statistical analyses showed relevant results. In no-apathy group, education was a significant predictor on impulsiveness (attentional and motor) and apathy (executive and emotional); depression was a significant predictor on planning impulsivity and apathy.This study aimed to consider the importance of apathy and impulsivity in Parkinson disease. Although these are considered as opposite extremes of a spectrum of motivated behavior dependent on dopaminergic dysfunction, these can also occur separately. Moreover, several variables could represent important predictors of apathy and impulsiveness, such as depression. Future investigations should deepen the role of other demographics and psychological variables. 相似文献
53.
Simona Sacco Faisal Mohammad Amin Messoud Ashina Lars Bendtsen Christina I. Deligianni Raquel Gil-Gouveia Zaza Katsarava Antoinette MaassenVanDenBrink Paolo Martelletti Dimos-Dimitrios Mitsikostas Raffaele Ornello Uwe Reuter Margarita Sanchez-del-Rio Alexandra J. Sinclair Gisela Terwindt Derya Uluduz Jan Versijpt Christian Lampl 《The journal of headache and pain》2022,23(1)
BackgroundA previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized controlled trials (RCTs) and real-world evidence have expanded the evidence and knowledge for those treatments. Therefore, the EHF panel decided to provide an updated guideline on the use of those treatments.MethodsThe guideline was developed following the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach. The working group identified relevant questions, performed a systematic review and an analysis of the literature, assessed the quality of the available evidence, and wrote recommendations. Where the GRADE approach was not applicable, expert opinion was provided.ResultsWe found moderate to high quality of evidence to recommend eptinezumab, erenumab, fremanezumab, and galcanezumab in individuals with episodic and chronic migraine. For several important clinical questions, we found not enough evidence to provide evidence-based recommendations and guidance relied on experts’ opinion. Nevertheless, we provided updated suggestions regarding the long-term management of those treatments and their place with respect to the other migraine preventatives.ConclusionMonoclonal antibodies targeting the CGRP pathway are recommended for migraine prevention as they are effective and safe also in the long-term.Supplementary InformationThe online version contains supplementary material available at 10.1186/s10194-022-01431-x. 相似文献
54.
Emmanuel de Billy Marsha Pellegrino Domenico Orlando Giulia Pericoli Roberta Ferretti Pietro Businaro Maria Antonietta Ajmone-Cat Sabrina Rossi Lucia Lisa Petrilli Nicola Maestro Francesca Diomedi-Camassei Marco Pezzullo Cristiano De Stefanis Paola Bencivenga Alessia Palma Rossella Rota Francesca Del Bufalo Luca Massimi Gerrit Weber Chris Jones Andrea Carai Simona Caruso Biagio De Angelis Ignazio Caruana Concetta Quintarelli Angela Mastronuzzi Franco Locatelli Maria Vinci 《Neuro-oncology》2022,24(7):1150
BackgroundDiffuse midline gliomas (DMG) H3K27M-mutant, including diffuse intrinsic pontine glioma (DIPG), are pediatric brain tumors associated with grim prognosis. Although GD2-CAR T-cells demonstrated significant anti-tumor activity against DMG H3K27M-mutant in vivo, a multimodal approach may be needed to more effectively treat patients. We investigated GD2 expression in DMG/DIPG and other pediatric high-grade gliomas (pHGG) and sought to identify chemical compounds that would enhance GD2-CAR T-cell anti-tumor efficacy.MethodsImmunohistochemistry in tumor tissue samples and immunofluorescence in primary patient-derived cell lines were performed to study GD2 expression. We developed a high-throughput cell-based assay to screen 42 kinase inhibitors in combination with GD2-CAR T-cells. Cell viability, western blots, flow-cytometry, real time PCR experiments, DIPG 3D culture models, and orthotopic xenograft model were applied to investigate the effect of selected compounds on DIPG cell death and CAR T-cell function.ResultsGD2 was heterogeneously, but widely, expressed in the tissue tested, while its expression was homogeneous and restricted to DMG/DIPG H3K27M-mutant cell lines. We identified dual IGF1R/IR antagonists, BMS-754807 and linsitinib, able to inhibit tumor cell viability at concentrations that do not affect CAR T-cells. Linsitinib, but not BMS-754807, decreases activation/exhaustion of GD2-CAR T-cells and increases their central memory profile. The enhanced anti-tumor activity of linsitinib/GD2-CAR T-cell combination was confirmed in DIPG models in vitro, ex vivo, and in vivo.ConclusionOur study supports the development of IGF1R/IR inhibitors to be used in combination with GD2-CAR T-cells for treating patients affected by DMG/DIPG and, potentially, by pHGG. 相似文献
55.
Antibacterial activity of 1,1′-methylenedipyrazole (AM1), 1-hydroxymethylpyrazole (SAM1), 1,1′-methylenediimidazole (AM2), and 1-hydroxymethylimidazole (SAM2) has been tested against reference and clinical strains by both difusimetric and broth dilution methods. Overall, the minimal inhibitory concentrations of tested compounds ranged from 180 to 270?μg/ml, while the minimal bactericidal concentrations were between 360 and 720?μg/ml. Comparative assessment with phenol and formaldehyde shows that AM1, AM2, SAM1, and SAM2 have moderate to good antibacterial activity. 相似文献
56.
57.
58.
59.
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia 下载免费PDF全文
60.
The Relationship between AKI and CKD in Patients with Type 2 Diabetes: An Observational Cohort Study